BR100 Increased By (1.66%)
BR30 Increased By (1.75%)
KSE100 Increased By (1.2%)
KSE30 Increased By (1.4%)
AGHA 7.48 Increased By ▲ 0.04 (0.54%)
BECO 5.30 No Change ▼ 0.00 (0%)
BML 57.22 Increased By ▲ 0.16 (0.28%)
BOP 33.92 Increased By ▲ 0.43 (1.28%)
CNERGY 11.10 Increased By ▲ 0.36 (3.35%)
CSIL 6.06 Increased By ▲ 0.02 (0.33%)
FCCL 55.90 Increased By ▲ 1.72 (3.17%)
FFL 16.08 Increased By ▲ 0.01 (0.06%)
FNEL 1.21 Decreased By ▼ -0.01 (-0.82%)
KEL 7.30 Increased By ▲ 0.12 (1.67%)
KOSM 6.10 Increased By ▲ 0.17 (2.87%)
LOTCHEM 27.29 Increased By ▲ 0.32 (1.19%)
MLCF 97.45 Increased By ▲ 2.58 (2.72%)
NBP 204.44 Increased By ▲ 4.15 (2.07%)
NCPL 56.15 Increased By ▲ 0.68 (1.23%)
NPL 65.98 Increased By ▲ 0.36 (0.55%)
OGDC 319.09 Increased By ▲ 5.05 (1.61%)
PACE 10.66 Increased By ▲ 0.15 (1.43%)
PAEL 42.52 Increased By ▲ 0.25 (0.59%)
PIBTL 17.08 Increased By ▲ 0.04 (0.23%)
PPL 221.32 Increased By ▲ 5.11 (2.36%)
PRL 63.42 Increased By ▲ 3.28 (5.45%)
PTC 72.49 Increased By ▲ 0.48 (0.67%)
SSGC 25.93 Increased By ▲ 0.65 (2.57%)
TBL 9.72 Increased By ▲ 0.05 (0.52%)
TELE 8.46 Increased By ▲ 0.21 (2.55%)
TPL 21.47 Increased By ▲ 1.14 (5.61%)
TPLP 14.71 Increased By ▲ 1.34 (10.02%)
TREET 23.19 Increased By ▲ 0.14 (0.61%)
TRG 60.81 Decreased By ▼ -0.04 (-0.07%)

Time, the world's leading newsweekly, in its cover story of May 5, 2008, has featured Qarshi's Johar Joshanda in its 'The Best of Asia' section. This is a singular honour for Pakistan and a matter of pride for Qarshi Industries. Time Reporter Aryn Baker, in his article 'Best for the Body,' has described Johar Joshanda as 'the national common denominator.'
He writes that when he arrived in Pakistan with a bad case of flu, and was asked to take Johar Joshanda, the effect was instant. "My scratchy throat was soothed, my cough subsided, and my sniffles slowed. And it tasted good..." Qarshi products are produced on state-of-the-art manufacturing facilities located in Hattar where strict international procedures are followed at all stages.-PR

Copyright Business Recorder, 2008

Comments

Comments are closed for this article.